Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial

Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial

Abstract Background Allergen specific immunotherapy (AIT) in elderly patients is controversial, and there is still little evidence supporting the safety and efficacy of this treatment in this population. The study objective was to evaluate the safety and efficacy of AIT for house dust mite allergens...

Full description

Bibliographic Details
Main Authors: Andrzej Bożek, Krzysztof Kołodziejczyk, Renata Kozłowska, Giorgio Walter Canonica
Format: Article
Language:English
Published: Wiley 2017-12-01
Series:Clinical and Translational Allergy
Subjects:
Immunotherapy
Allergic rhinitis
Elderly
House dust mite
Online Access:http://link.springer.com/article/10.1186/s13601-017-0180-9

Internet

http://link.springer.com/article/10.1186/s13601-017-0180-9

Similar Items